Literature DB >> 24216762

An investigation of the effects of the core protein telomerase reverse transcriptase on Wnt signaling in breast cancer cells.

Imke Listerman1, Francesca S Gazzaniga, Elizabeth H Blackburn.   

Abstract

Telomerase canonically maintains telomeres, but recent reports have suggested that the core protein mammalian telomerase reverse transcriptase (TERT) component, together with the chromatin remodeling factor BRG1 and β-catenin, may also bind to and promote expression of Wnt target genes. However, this proposed noncanonical role of TERT in Wnt signaling has been controversial. Here, we investigated the effects of human TERT (hTERT) on Wnt signaling in human breast cancer lines and HeLa cells. We failed to find evidence for physical association of hTERT with BRG1 or β-catenin; instead, we present evidence that anti-FLAG antibody cross-reactivity properties may explain the previously reported interaction of hTERT with β-catenin. Furthermore, altering hTERT levels in four different breast cancer cell lines caused minimal and discordant effects on Wnt target and Wnt pathway gene expression. Although hTERT's role in Wnt signaling was addressed only indirectly, no significant representation of Wnt target genes was detected in chromatin immunoprecipitation-sequencing (ChIP-seq) and chromatin isolation by RNA purification and sequencing (ChIRP-seq) loci cooccupied in HeLa S3 cells by both BRG1 and hTR. In summary, our evidence fails to support the idea of a biologically consistent hTERT interaction with the Wnt pathway in human breast cancer cells, and any detectable influence of hTERT depended on cell type and experimental system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24216762      PMCID: PMC3911296          DOI: 10.1128/MCB.00844-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Separation of telomerase functions by reverse genetics.

Authors:  Shibani Mukherjee; Eduardo J Firpo; Yang Wang; James M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

2.  Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells.

Authors:  Katrin Hoffmeyer; Angelo Raggioli; Stefan Rudloff; Roman Anton; Andreas Hierholzer; Ignacio Del Valle; Kerstin Hein; Riana Vogt; Rolf Kemler
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

Review 3.  Wnt signaling in stem and cancer stem cells.

Authors:  Jane D Holland; Alexandra Klaus; Alistair N Garratt; Walter Birchmeier
Journal:  Curr Opin Cell Biol       Date:  2013-01-21       Impact factor: 8.382

4.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

5.  Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions.

Authors:  Ci Chu; Kun Qu; Franklin L Zhong; Steven E Artandi; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-29       Impact factor: 17.970

Review 6.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

7.  Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Henry R Bose
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

8.  The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis.

Authors:  Imke Listerman; Jie Sun; Francesca S Gazzaniga; Jason L Lukas; Elizabeth H Blackburn
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

9.  Telomerase directly regulates NF-κB-dependent transcription.

Authors:  Arkasubhra Ghosh; Gaye Saginc; Shi Chi Leow; Ekta Khattar; Eun Myong Shin; Ting Dong Yan; Marc Wong; Zhizhuo Zhang; Guoliang Li; Wing-Kin Sung; Jianbiao Zhou; Wee Joo Chng; Shang Li; Edison Liu; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2012-11-18       Impact factor: 28.824

10.  Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.

Authors:  Yong Zhang; LingLing Toh; Peishan Lau; Xueying Wang
Journal:  J Biol Chem       Date:  2012-07-31       Impact factor: 5.157

View more
  25 in total

Review 1.  The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance.

Authors:  Jonathan H Teichroeb; Joohwan Kim; Dean H Betts
Journal:  RNA Biol       Date:  2016-01-19       Impact factor: 4.652

2.  Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.

Authors:  Sumit Borah; Linghe Xi; Arthur J Zaug; Natasha M Powell; Garrett M Dancik; Scott B Cohen; James C Costello; Dan Theodorescu; Thomas R Cech
Journal:  Science       Date:  2015-02-05       Impact factor: 47.728

Review 3.  The non-canonical functions of telomerase: to turn off or not to turn off.

Authors:  Aleksandra Romaniuk; Anna Paszel-Jaworska; Ewa Totoń; Natalia Lisiak; Hanna Hołysz; Anna Królak; Sylwia Grodecka-Gazdecka; Błażej Rubiś
Journal:  Mol Biol Rep       Date:  2018-11-17       Impact factor: 2.316

Review 4.  Transcriptional outcome of telomere signalling.

Authors:  Jing Ye; Valérie M Renault; Karine Jamet; Eric Gilson
Journal:  Nat Rev Genet       Date:  2014-06-10       Impact factor: 53.242

Review 5.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

Review 6.  Stress and immunosenescence: The role of telomerase.

Authors:  Karin de Punder; Christine Heim; Pathik D Wadhwa; Sonja Entringer
Journal:  Psychoneuroendocrinology       Date:  2018-10-23       Impact factor: 4.905

Review 7.  Wnts and the hallmarks of cancer.

Authors:  Zheng Zhong; Jia Yu; David M Virshup; Babita Madan
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 8.  When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM.

Authors:  Saumya R Bollam; Michael E Berens; Harshil D Dhruv
Journal:  Curr Neurol Neurosci Rep       Date:  2018-03-10       Impact factor: 5.081

Review 9.  A regulatory loop connecting WNT signaling and telomere capping: possible therapeutic implications for dyskeratosis congenita.

Authors:  Rafael Jesus Fernandez; F Brad Johnson
Journal:  Ann N Y Acad Sci       Date:  2018-04       Impact factor: 5.691

10.  Involvement of telomerase reverse transcriptase in heterochromatin maintenance.

Authors:  Yoshiko Maida; Mami Yasukawa; Naoko Okamoto; Seii Ohka; Keita Kinoshita; Yasushi Totoki; Takashi K Ito; Tohru Minamino; Hiromi Nakamura; Satoko Yamaguchi; Tatsuhiro Shibata; Kenkichi Masutomi
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.